BeiGene Ltd.

BeiGene Ltd. (now BeOne Medicines AG) is a Basel‑based oncology biopharma with commercial assets BRUKINSA, TEVIMBRA, PARTRUVIX and a broad clinical pipeline, supported by strategic partnerships with Amgen, BMS, Novartis, etc.

Headquarters: China (CHN)

BeiGene Ltd. Logo
Company Profile
  • Employees: 11,000
  • HQ: Basel
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
49BA BeiGene Ltd. Sponsored ADR
Cap: 31.9B | P/E: 669.8
EQUITY FRA EUR US07725L1026 Active
📈
Home Login